Interferon. induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells

被引:29
|
作者
Guan, Qingdong [1 ,2 ]
Ezzati, Peyman [3 ,4 ]
Spicer, Victor [3 ,4 ]
Krokhin, Oleg [3 ,4 ]
Wall, Donna [5 ]
Wilkins, John A. [3 ,4 ]
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Manitoba Ctr Adv Cell & Tissue Therapy, Winnipeg, MB, Canada
[2] CancerCare Manitoba, Cellular Therapy Lab, Winnipeg, MB, Canada
[3] Univ Manitoba, Rady Fac Hlth Sci, Dept Internal Med, Manitoba Ctr Prote & Syst Biol,Sect Biomed Prote, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[4] 799 John Buhler Res Ctr, Hlth Sci Ctr, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[5] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON, Canada
关键词
Proteomics; Human; 2D LC mass spectrometry; Interferon gamma; Mesenchymal stem/stromal cells ( MSC); Quantitative proteome profiling; Licensing; Membrane; STROMAL CELLS; STEM-CELLS; IFN-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; PROSTACYCLIN SYNTHASE; TGF-BETA; INDUCTION; IMMUNOSUPPRESSION; SUPPRESSION; ACTIVATION;
D O I
10.1186/s12014-017-9161-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Mesenchymal stem/stromal cells ( MSC) display a range of immunoregulatory properties which can be enhanced by the exposure to cytokines such interferon. ( IFN-gamma).However the compositional changes associated with the 'licensing' of these cells have not been clearly defined. The present study was undertaken to provide a detailed comparative proteomic analysis of the compositional changes that occur in human bone marrow derived MSC following 20 h treatment with IFN-gamma. Methods: 2D LC MSMS analysis of control and IFN-gamma treated cells from 5 different healthy donors provided confident identification of more than 8400 proteins. Results: In total 210 proteins were shown to be significantly altered in their expression levels (>=|2SD|) following IFN-gamma treatment. The changes for several of these proteins were confirmed by flow cytometry. STRING analysis determined that approximately 30% of the altered proteins physically interacted in described interferon mediated processes. Comparison of the list of proteins that were identified as changed in the proteomic analysis with data for the same proteins in the Interferome DB indicated that similar to 35% of these proteins have not been reported to be IFN-gamma responsive in a range of cell types. Conclusions: This data provides an in depth analysis of the proteome of basal and IFN-gamma treated human mesenchymal stem cells and it identifies a number of novel proteins that may contribute to the immunoregulatory capacity if IFN-gamma licensed cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Interferon γ induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells
    Qingdong Guan
    Peyman Ezzati
    Victor Spicer
    Oleg Krokhin
    Donna Wall
    John A. Wilkins
    Clinical Proteomics, 2017, 14
  • [2] Transcatheter Injection-Induced Changes in Human Bone Marrow-Derived Mesenchymal Stem Cells
    Heng, Boon C.
    Hsu, Steven H.
    Cowan, Catherine M.
    Liu, Annie
    Tai, Julie
    Chan, Yen
    Sherman, Warren
    Basu, Shubhayu
    CELL TRANSPLANTATION, 2009, 18 (10-11) : 1111 - 1121
  • [3] Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells
    Lipat, Ariel Joy
    Cottle, Chasen
    Pirlot, Bonnie M.
    Mitchell, James
    Pando, Brian
    Helmly, Brian
    Kosko, Joanna
    Rajan, Devi
    Hematti, Peiman
    Chinnadurai, Raghavan
    STEM CELLS TRANSLATIONAL MEDICINE, 2022, 11 (09) : 971 - 986
  • [4] Mesenchymal stromal/stem cells markers in the human bone marrow
    Rasini, Valeria
    Dominici, Massimo
    Kluba, Torsten
    Siegel, Georg
    Lusenti, Giulia
    Northoff, Hinnak
    Horwitz, Edwin M.
    Schaefer, Richard
    CYTOTHERAPY, 2013, 15 (03) : 292 - 306
  • [5] Galectin-9 is Involved in Immunosuppression Mediated by Human Bone Marrow-derived Clonal Mesenchymal Stem Cells
    Kim, Si-na
    Lee, Hyun-Joo
    Jeon, Myung-Shin
    Yi, TacGhee
    Song, Sun U.
    IMMUNE NETWORK, 2015, 15 (05) : 241 - 251
  • [6] Comparison of Immunological Characteristics of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells and Bone Marrow
    Fu, Xin
    Chen, Yao
    Xie, Fang-Nan
    Dong, Ping
    Liu, Wen-bo
    Cao, Yilin
    Zhang, Wen-Jie
    Xiao, Ran
    TISSUE ENGINEERING PART A, 2015, 21 (3-4) : 616 - 626
  • [7] Secretome analysis of human bone marrow derived mesenchymal stromal cells
    Baberg, Falk
    Geyh, Stefanie
    Waldera-Lupa, Daniel
    Stefanski, Anja
    Zilkens, Christoph
    Haas, Rainer
    Schroeder, Thomas
    Stuehler, Kai
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2019, 1867 (04): : 434 - 441
  • [8] Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells
    Ryan, Molly Mercedes
    Patel, Mihir
    Hogan, Keenan
    Lipat, Ariel Joy
    Scandolara, Rafaela
    Das, Rahul
    Bruker, Charles
    Galipeau, Jacques
    Chinnadurai, Raghavan
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 389.e1 - 389.e10
  • [9] Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow
    Brown, Patrick T.
    Squire, Matthew W.
    Li, Wan-Ju
    CELL AND TISSUE RESEARCH, 2014, 358 (01) : 149 - 164
  • [10] The anti-inflammatory property of human bone marrow-derived mesenchymal stem/stromal cells is preserved in late-passage cultures
    Song, Dandan
    Ohtaki, Hirokazu
    Tsumuraya, Tomomi
    Miyamoto, Kazuyuki
    Shibato, Junko
    Rakwal, Randeep
    Xu, Zhifang
    Hiraizumi, Yutaka
    Inoue, Tomio
    Shioda, Seiji
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 263 (1-2) : 55 - 63